无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜

全、新、優(yōu)、品、好四大特點(diǎn)：

微管相關(guān)蛋白抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

微管相關(guān)蛋白抗體說明書 英文名稱  Anti-Tau protein

中文名稱  微管相關(guān)蛋白抗體說明書 

別    名 MAPT; Microtuble-associted protein Tau; AI413597; AW045860; DDPAC; Disinhibition dementia parkinsonism amyotrophy complex; FLJ31424; FTDP 17; FTDP17; G Protein beta 1 gamma 2 subunit interacting factor 1; G protein beta1/gamma2 subunit interacting factor 1; MAPTL; MGC134287; MGC138549; MGC156663; Microtubule associated protein tau isoform 4; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; Paired helical filament tau; PHF tau; PHF-tau; PPND; pTau; RNPTAU; Tauopathy and respiratory failure, included; TAU_HUMAN.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Rabbit

產(chǎn)品類型   一抗  

研究領(lǐng)域    細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡

蛋白分子量  predicted molecular weight: 83kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Tau protein (705-729aa)

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

微管相關(guān)蛋白抗體說明書 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 Tau proteins are important Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by tau localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. Tau proteins subcellular located in the axons of neurons, in the cytoso l and in association with plasma membrane components. It expressed in neurons. PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.

Function : Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.

Subunit : Interacts with PSMC2 through SQSTM. Interacts with SQSTM1 when polyubiquitinated. Interacts with FKBP4. Binds to CSNK1D. Interacts with SGK1.

Subcellular Location : Cytoplasm, cytosol. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, cytoskeleton. Cell projection, axon. Note=Mostly found in the axons of neurons, in the cytosol and in association with plasma membrane components.

Tissue Specificity : Expressed in neurons. Isoform PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.

Post-translational modifications : Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1: CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1 or MARK2), causing detachment from microtubules, and their disassembly. Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tAU/MAP's interaction with, respectively, microtubules or plasma membrane components. Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717.

Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome. PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.

O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.

Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle

DISEASE : Note=In Alzheimer disease, the neuronal cytoskeleton in the brain is progressively disrupted and replaced by tangles of paired helical filaments (PHF) and straight filaments, mainly composed of hyperphosphorylated forms of TAU (PHF-TAU or AD P-TAU). O-GlcNAcylation is greatly reduced in Alzheimer disease brain cerebral cortex leading to an increase in TAU/MAPT phosphorylations.

Defects in MAPT are a cause of frontotemporal dementia (FTD) [MIM:600274]; also called frontotemporal dementia (FTD), pallido-ponto-nigral degeneration (PPND) or historically termed Pick complex. This form of frontotemporal dementia is characterized by presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. In some cases, parkinsonian symptoms are prominent. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia, substantia nigra, amygdala. In most cases, protein tau deposits are found in glial cells and/or neurons.

Defects in MAPT are a cause of Pick disease of the brain (PIDB) [MIM:172700]. It is a rare form of dementia pathologically defined by severe atrophy, neuronal loss and gliosis. It is characterized by the occurrence of tau-positive inclusions, swollen neurons (Pick cells) and argentophilic neuronal inclusions known as Pick bodies that disproportionally affect the frontal and temporal cortical regions. Clinical features include aphasia, apraxia, confusion, anomia, memory loss and personality deterioration.

Note=Defects in MAPT are a cause of corticobasal degeneration (CBD). It is marked by extrapyramidal signs and apraxia and can be associated with memory loss. Neuropathologic features may overlap Alzheimer disease, progressive supranuclear palsy, and Parkinson disease.

Defects in MAPT are a cause of progressive supranuclear palsy type 1 (PSNP1) [MIM:601104]; also abbreviated as PSP and also known as Steele-Richardson-Olszewski syndrome. PSNP1 is characterized by akinetic-rigid syndrome, supranuclear gaze palsy, pyramidal tract dysfunction, pseudobulbar signs and cognitive capacities deterioration. Neurofibrillary tangles and gliosis but no amyloid plaques are found in diseased brains. Most cases appear to be sporadic, with a significant association with a common haplotype including the MAPT gene and the flanking regions. Familial cases show an autosomal dominant pattern of transmission with incomplete penetrance; genetic analysis of a few cases showed the occurrence of tau mutations, including a deletion of Asn-613.

Defects in MAPT are a cause of Parkinson-dementia syndrome (PARDE) [MIM:260540]. A syndrome characterized by parkinsonism tremor, rigidity, dementia, ophthalmoparesis and pyramidal signs. Neurofibrillary degeneration occurs in the hippocampus, basal ganglia and brainstem nuclei.

Similarity : Contains 4 Tau/MAP repeats.

Database links : UniProtKB/Swiss-Prot: P10636.5

tau蛋白是腦內(nèi)神經(jīng)元細(xì)胞支架蛋白之一.其正常功能是促進(jìn)微管蛋白組成微管,并維持已形成微管的穩(wěn)定性.參與維持細(xì)胞形態(tài)、信息傳遞、細(xì)胞分裂等重要生物學(xué)過程,是軸突和神經(jīng)元極性形成的不可缺少因素.

近年來發(fā)現(xiàn)tau蛋白與一些中樞變性疾病密切相關(guān),尤其是神經(jīng)Tau具有啟動(dòng)微管系統(tǒng)的裝配以及穩(wěn)定微管系統(tǒng)的作用，該蛋白的錯(cuò)誤折疊與等神經(jīng)退行性疾病密切相關(guān).

實(shí)驗(yàn)流程：

正在熱銷的相關(guān)產(chǎn)品：

Angiotensin II receptor(Ang II ) 緊張素Ⅱ受體(抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-Phospho-Beta-Catenin (Ser552) 磷酸化β 連環(huán)素蛋白抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh PCDHGB1 原鈣粘蛋白γB1抗體 規(guī)格 0.2ml

IL12B Kit Human 人 IL12B / NKSF2 / p40 ELISA配對(duì)抗體 ELISA

TRAP80 英文名稱： MED17抗體 0.2ml

phospho-CBL2 (Tyr731) 英文名稱： 磷酸化原癌蛋白CBL2抗體 0.1ml

Anti-Phospho-Beta-Catenin (Ser552) 磷酸化β 連環(huán)素蛋白抗體Multi-class antibodies規(guī)格： 0.1ml

ACTH ELISA Kit 大鼠促腎上腺皮質(zhì)激素Multi-class antibodies規(guī)格： 48T

Anti-AT1R/FITC 熒光素標(biāo)記緊張素Ⅱ-1型受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh FAIM3 FAS凋亡抑制分子3抗體 規(guī)格 0.2ml

BMG/ Beta2-MG ELISA Kit 大鼠β2微球蛋白 96T

M2-PK (pyruvate Kinase M2) 英文名稱： 酸激酶-M2 0.1ml

ADH5 英文名稱： 乙醇脫氫酶5抗體 0.2ml

Anti-AT1R/FITC 熒光素標(biāo)記緊張素Ⅱ-1型受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-SLC40A1/FPN1/FITC 熒光素標(biāo)記細(xì)胞膜鐵轉(zhuǎn)運(yùn)蛋白SLC40A1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Calponin 1 鈣調(diào)節(jié)蛋白-1(抗原)Multi-class antibodies規(guī)格： 0.5mg

原癌基因抗體 Anti-N-ras 0.1ml

Synaptotagmin X 英文名稱： 突觸結(jié)合蛋白10抗體 0.2ml

EVC2 英文名稱： 膜蛋白EVC2抗體 0.1ml

Rhesus antibody Rh phospho-p23 (Ser113) 磷酸化端粒酶結(jié)合蛋白P23抗體 規(guī)格 0.1ml

Calponin 1 鈣調(diào)節(jié)蛋白-1(抗原)Multi-class antibodies規(guī)格： 0.5mg

大鼠尿激酶型纖溶酶原激活物受體(PLAUR/uPAR)ELISA試劑盒 ，英文名： PLAUR/uPAR ELISA Kit

人干擾素誘導(dǎo)蛋白10(IP-10/CXCL10)ELISA檢測(cè)試劑盒Humanierferon-inducibleprotein10,IP-10ELISAKit 96T/48T

魚酚氧化酶(PO)免疫試劑盒 Fish phenol oxidase,PO ELISA Kit

CLIAKitforPCT(MouseProcalcitonin)ELISAKit小鼠降鈣素原規(guī)格：48T/96T

樹脂法骨DNA萃取試劑盒20次

ELISAKitC3b人補(bǔ)體片斷3b規(guī)格：48T/96T

大鼠促甲狀腺激素(TSH)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝

人免疫球蛋白輕鏈lambda(λ-IgLC)免疫試劑盒 Human lambda immunoglobulin light chain,λ-IgLC ELISA Kit

MouseoponinⅠ,Tn-ⅠELISAKit小鼠肌鈣蛋白Ⅰ(Tn-Ⅰ)ELISA試劑盒規(guī)格：96T/48T

羥脯氨酸(HYP)終點(diǎn)比色法定量檢測(cè)試劑盒50次

Humanpro-gasin-releasingpeptide,ProGRPELISA試劑盒人胃泌素釋放肽前體(ProGRP)ELISA試劑盒規(guī)格：96T/48T

Humahrombieceptor,ELISAKit人凝血酶受體()ELISA試劑盒規(guī)格：96T/48T

微管相關(guān)蛋白抗體說明書 大鼠法尼基二磷酸合酶(FDPS)ELISA試劑盒 ，英文名： FDPS ELISA Kit

Rat ierleukin 1 (IL-1) ELISA Kit 大鼠白介素1(IL-1)ELISA試劑盒

RatThrombopoietin,TPOELISAkit 大鼠血小板生成素(TPO)ELISA試劑盒 96T/48T 進(jìn)口分裝

CLIAKitforDHEA-S7(HumanDehydroepiandrosteroneS7)ELISAKit人脫氫表雄同S7規(guī)格：48T/96T

細(xì)胞溶酶體脂酶(酸性脂酶)活性比色法定量檢測(cè)試劑盒20次

RatGrowthHormoneReleasingPeptide,GHRPELISAKit大鼠生長(zhǎng)激素釋放多肽(GHRP)ELISA試劑盒規(guī)格：96T/48T

技術(shù)外包服務(wù):

★微管相關(guān)蛋白抗體說明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。